BMS awarded 2018 ENERGY STAR Partner of the Year Sustained Excellence Award

3 Apr 2018

The company’s environmental efforts honored for the fourth consecutive year.

The US Environmental Protection Agency (EPA) and the US Department of Energy have recognized Bristol-Myers Squibb (BMS) with an ENERGY STAR Partner of the Year Sustained Excellence Award for outstanding efforts to improve the energy efficiency of facilities worldwide. BMS has earned the ENERGY STAR Partner of the Year award for the past 4 consecutive years.

BMS awarded 2018 ENERGY STAR Partner of the Year Sustained Excellence Award

The award confirms BMS’s long-term commitment to environmental responsibility through driving sustainable improvements in energy with a goal of reducing the company use or resources across its drug discovery, development and delivery pipeline.

“We are proud to receive the ENERGY STAR Partner of the Year designation for 4 years, and to increase our recognition with the Sustained Excellence Award,” said Carol Ryerkerk Powell, vice president of Environment, Health, Safety and Sustainability, BMS. “To continue developing innovative medicines for our patients, we have to embrace our responsibility to support our environment, employees and communities. We look forward to our continued partnership with ENERGY STAR to better advance our energy management programs and demonstrate our leadership within the pharmaceutical industry.”

BMS was recognized for the following accomplishments:
  • Achieving an annual energy intensity improvement of more than $% globally, contributing to an 11.3% reduction in energy consumption since 2013.
  • Assisting the ENERGY STAR program with energy treasure hunt training for healthcare energy managers and conducting a treasure hunt with an external organization, St Joseph’s Medical Center in Bloomington, Illinois.
  • Achieving the ENERGY STAR Challenge for Industry at two sites and taking the challenge at eight new sites.
  • Hosting the first ENERGY STAR showcase event at a pharmaceutical facility that engaged employees, local government officials and ENERGY STAR industrial partners.
  • Earning ENERGY STAR certification at two office buildings.
  • Actively participating in the ENERGY STAR Focus on Energy Efficiency in Pharmaceutical Manufacturing and the ENERGY STAR industrial partnership.
  • Investing over $42.4 million across 342 energy projects to achieve an annualized savings of over $18.3 million since 2010.
  • In addition to the company’s recognition as an ENERGY STAR Partner of the Year, BMS’s R&D site in Hopewell, New Jersey, and the manufacturing site in New Brunswick, New Jersey earned the 2017 Challenge for Industry recognition. The ENERGY STAR Challenge for Industry is a national call-to-action to improve energy efficiency of America’s manufacturers by 10% or more. By taking the ENERGY STAR Challenge, sites set a goal to reduce their energy intensity by 10% within 5 years.

    Read More

    Related tags

    Market News

    Related news

    TraceLink unveils Product Information Manager for its digital information sharing platform

    TraceLink unveils Product Information Manager for its digital information sharing platform

    12 Jul 2018

    Product Information Manager addresses a broad range of use cases, beginning with saleable returns.

    Read more 
    Stability studies trends

    Stability studies trends

    10 Jul 2018

    Dr Ramesh Jagadeesan, Sr. Director - Analytical Development at Recipharm, speaks to CPhI Online on the trends and challenges involved with conducting stability studies for firms that supply to multiple countries, and the advantages of using a contracto...

    Read more 
    Recipharm launches standalone serialisation service

    Recipharm launches standalone serialisation service

    5 Jul 2018

    Company will be able to add 2D codes, human-readable text and tamper evidence to pre-packed medicines using existing equipment across its facilities.

    Read more 
    CPhI Worldwide opens entries for 15th Annual Pharma Awards

    CPhI Worldwide opens entries for 15th Annual Pharma Awards

    5 Jul 2018

    Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.

    Read more 
    Catalent to acquire Juniper Pharmaceuticals

    Catalent to acquire Juniper Pharmaceuticals

    5 Jul 2018

    $133 million deal adds European Early Development Center of Excellence to global network.

    Read more 
    Insights in lyophilization science

    Insights in lyophilization science

    4 Jul 2018

    The latest developments in process development, nucleation control, scale-up of freeze drying cycles and development in lyophilization technology.

    Read more 
    Bosch to sell its packaging business

    Bosch to sell its packaging business

    4 Jul 2018

    Packaging technology is not a core Bosch business.

    Read more 
    Plasticell leads gene therapy manufacturing consortium

    Plasticell leads gene therapy manufacturing consortium

    3 Jul 2018

    Consortium to develop advanced technologies for the manufacturing of ex vivo gene therapies.

    Read more 
    Forté Pharma strengthens its leadership in weight control in France

    Forté Pharma strengthens its leadership in weight control in France

    1 Jul 2018

    Company consolidated as one of the leading laboratories in weight control thanks to the development of its existing range and new launches.

    Read more 
    I Holland woos exhibition visitors with new tabletting technologies

    I Holland woos exhibition visitors with new tabletting technologies

    28 Jun 2018

    Company's Wear Indicator Layer attracts the most attention.

    Read more